Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis
- 31 January 2019
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 380 (5), 415-424
- https://doi.org/10.1056/nejmoa1808312
Abstract
Patients with infective endocarditis on the left side of the heart are typically treated with intravenous antibiotic agents for up to 6 weeks. Whether a shift from intravenous to oral antibiotics once the patient is in stable condition would result in efficacy and safety similar to those with continued intravenous treatment is unknown. In a randomized, noninferiority, multicenter trial, we assigned 400 adults in stable condition who had endocarditis on the left side of the heart caused by streptococcus, Enterococcus faecalis, Staphylococcus aureus, or coagulase-negative staphylococci and who were being treated with intravenous antibiotics to continue intravenous treatment (199 patients) or to switch to oral antibiotic treatment (201 patients). In all patients, antibiotic treatment was administered intravenously for at least 10 days. If feasible, patients in the orally treated group were discharged to outpatient treatment. The primary outcome was a composite of all-cause mortality, unplanned cardiac surgery, embolic events, or relapse of bacteremia with the primary pathogen, from the time of randomization until 6 months after antibiotic treatment was completed. After randomization, antibiotic treatment was completed after a median of 19 days (interquartile range, 14 to 25) in the intravenously treated group and 17 days (interquartile range, 14 to 25) in the orally treated group (P=0.48). The primary composite outcome occurred in 24 patients (12.1%) in the intravenously treated group and in 18 (9.0%) in the orally treated group (between-group difference, 3.1 percentage points; 95% confidence interval, −3.4 to 9.6; P=0.40), which met noninferiority criteria. In patients with endocarditis on the left side of the heart who were in stable condition, changing to oral antibiotic treatment was noninferior to continued intravenous antibiotic treatment. (Funded by the Danish Heart Foundation and others; POET ClinicalTrials.gov number, NCT01375257.)Keywords
Funding Information
- Svend Aage Andersens Foundation
- The Danish Heart Foundation
- The Hartmann’s Foundation
- The Capital Regions Research Council
This publication has 27 references indexed in Scilit:
- Partial oral treatment of endocarditisAmerican Heart Journal, 2013
- Patients Perspective on Endocarditis — An Intermezzo in LifeEuropean Journal of Cardiovascular Nursing, 2010
- Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in AustraliaEuropean Heart Journal, 2010
- Health‐Related Quality of Life and Posttraumatic Stress Disorder among Survivors of Left‐Sided Native Valve EndocarditisClinical Infectious Diseases, 2009
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st CenturyJAMA Internal Medicine, 2009
- Fast-track colorectal surgeryThe Lancet, 2008
- A Prospective Randomized Controlled Trial of Multimodal Perioperative Management Protocol in Patients Undergoing Elective Colorectal Resection for CancerAnnals of Surgery, 2007
- Analysis of mortality and risk factors associated with native valve endocarditis in drug users: The importance of vegetation sizeAmerican Heart Journal, 2005
- TREATMENT OF RIGHT-SIDED STAPHYLOCOCCUS AUREUS ENDOCARDITIS IN INTRAVENOUS DRUG USERS WITH CIPROFLOXACIN AND RIFAMPICINThe Lancet, 1989
- The Lewis A. Conner Lecture of the American Heart AssociationCirculation, 1950